PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PDAC - PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smart drug home in on Hard-to-Treat GI cancers?
Disease control Not yet recruitingThis early-stage trial is testing an experimental treatment called the IKS04 regimen in people with advanced cancers of the digestive system, including colorectal, stomach, pancreatic, and bile duct cancers. The regimen combines a targeted antibody-drug conjugate with an addition…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Iksuda Therapeutics Ltd. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Triple threat: radiation and immunotherapy join chemo against pancreatic cancer
Disease control Not yet recruitingThis Phase III trial tests whether adding targeted radiation and an immunotherapy drug (serplulimab) to standard chemotherapy can help people with advanced pancreatic cancer live longer. About 198 participants who have not had prior treatment will be randomly assigned to receive …
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Personalized cancer test could take guesswork out of treatment
Knowledge-focused Not yet recruitingThis study is testing a new approach to personalize cancer treatment for people with colorectal or pancreatic cancer. Researchers will take a small sample of a patient's tumor, grow it in the lab, and test different drugs on it to see which one works best. The goal is to see if t…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Massive cancer registry aims to unlock better GI cancer care
Knowledge-focused Not yet recruitingThis study is a registry that collects medical information and biological samples from up to 100,000 people with gastrointestinal cancers, such as pancreatic or colorectal cancer. No new treatments or drugs are given. The goal is to gather real-world data to help researchers answ…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Canopy Cancer Collective, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC